We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 17 for:    Recruiting, Not yet recruiting, Available Studies | "Home Care Services"

Implementation of a Return Home With a Hospitalization at Home or With a Home Health Care Provider From the Services of Oncopneumology, Oncology and Hematology of University Hospital of Strasbourg

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03217864
Recruitment Status : Recruiting
First Posted : July 14, 2017
Last Update Posted : July 14, 2017
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:

Hospitalization at home is booming. It is designed to meet the demands of patients and their families to continue care at home. It partially solves the problem of the lack of places in the "long-term care" structures and allows to respond to a desire of the health policy to reduce the lengths of stay in the hospital. Hospitalization at home is also an alternative in the management of chronic patients. Nevertheless, at the moment a certain number of requests for hospitalization at home remain unsuccessful or their implementation is complicated. In addition, the number of home health care provider has increased significantly in recent years. According to the federation of home health care provider, the number of beneficiaries increased by 1.7% in 4 years. The home health care provider would support 1,200,000 patients per year.

The objective of the study is to analyze the factors participating in Implementation of a return home with a Hospitalization at home or a home health care provider during a return home project constructed with the patient and his / her relatives from the services of Oncology, oncology, hematology of the University Hospital of Strasbourg.


Condition or disease
Cancer

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Implementation of a Return Home With a Hospitalization at Home or With a Home Health Care Provider From the Services of Oncopneumology, Oncology and Hematology of University Hospital of Strasbourg: Observational, Prospective, Monocentric, Non-interventional Study. Advantages, Disadvantages, Limitations
Actual Study Start Date : July 12, 2017
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : July 2018

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. Analysis of factors participating in Implementation of a return home with a Hospitalization at home or a home health care provider [ Time Frame: 15 days after patient discharge from hospital ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient over 18 years old for whom an application for Hospitalization at home or with a home health provider is initiated by the Oncology, Oncology or Hematology Department of of the University Hospital of Strasbourg.
Criteria

Inclusion Criteria:

  • Patient over 18 years old
  • Patient for whom an application for Hospitalization at home or with a home health provider is initiated by the Oncology, Oncology or Hematology Department of the University Hospital of Strasbourg.

Exclusion Criteria:

  • Refusal to participate in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03217864


Contacts
Contact: Laurent CALVEL, MD, PhD 33 3 88 12 83 39 laurent.calvel@chru-strasbourg.fr
Contact: Marie DEMEUSE, MD 33 3 88 12 83 39 marie.demeuse@chru-strasbourg.fr

Locations
France
Service Soins Palliatifs Recruiting
Strasbourg, France, 67098
Contact: Laurent CALVEL    33 3 88 12 83 39    laurent.calvel@chru-strasbourg.fr   
Contact: Marie DEMEUSE, MD    33 3 88 12 83 39    marie.demeuse@chru-strasbourg.fr   
Principal Investigator: Laurent CALVEL, MD, PhD         
Sub-Investigator: Marie DEMEUSE, MD         
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Study Director: Laurent CALVEL, MD, PhD University Hospital, Strasbourg, France
Principal Investigator: Marie DEMEUSE, MD University Hospital, Strasbourg, France

Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT03217864     History of Changes
Other Study ID Numbers: 6843
First Posted: July 14, 2017    Key Record Dates
Last Update Posted: July 14, 2017
Last Verified: July 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University Hospital, Strasbourg, France:
Cancer
palliative care
hospitalization at home
home health care provider